Navigation Links
Simple Test May Spot Early Lung Cancer
Date:4/7/2010

And over-the-counter drug might reverse genetic process that leads to disease, study finds

WEDNESDAY, April 7 (HealthDay News) -- Researchers may have found an easy way to detect lung cancer in its early or even pre-cancerous stages, as well as a way to reverse the start of the deadly disease with a readily available, over-the-counter drug.

"It's incredibly, incredibly exciting," said Dr. Patrick Nana-Sinkam, a lung cancer expert with the Ohio State University Comprehensive Cancer Center, who was not involved with the new study. "This definitely has potential."

The minimally invasive procedure involves using a small brush to collect a smattering of cells from the windpipe (a bronchoscopy), explained study co-author Andrea Bild, an assistant professor of pharmacology and toxicology at the University of Utah in Salt Lake City.

Maybe one day, screening could be done using an even simpler nasal or sputum test, the researchers said.

Currently, there is no good way to detect lung cancer -- the number one cancer killer -- in its early stages when it's most treatable. By the time most lung cancers are diagnosed -- which usually involves an invasive examination of the lungs -- patients already have advanced malignancies. Only 15 percent of patients are still alive at five years, said Nana-Sinkam.

Cigarette smoking is responsible for 90 percent of all lung cancer cases in the United States.

Still, only 10 to 20 percent of smokers actually develop lung cancer, begging the question: Why do some smokers succumb to the disease and others don't.

Now genomics may have provided an answer.

Working on the theory that cigarettes harm not only the lungs but a "field of injury" extending to other areas of the respiratory tract, the study authors surmised that evidence of existing or soon-to-develop lung cancer might be available further up in the airway.

The researchers used so-called microarray genetic analysis to measure gene expression levels in the epithelial cells -- those cells lining the respiratory tract -- that they had captured with the bronchoscopy.

"We were looking at the activity of genes in the cells that we obtained from the windpipe or airways of smokers at risk for lung cancer," said study senior author Dr. Avrum Spira, a critical care physician at Boston Medical Center and associate professor of medicine, pathology and bioinformatics at Boston University School of Medicine.

It turned out that gene activity in the PI3K pathway was "off the chart" in smokers with lung cancer versus those without the disease.

"Obviously that's very exciting," Spira said. "We have identified a marker for an early risk of developing lung cancer."

And when treated with the compound myo-inositol, the gene pathway activity declined along with improvement in the troublesome lesions, the researcher noted.

"This drug inhibits the pathway that's activated in smokers. The drug is a natural compound. You can get it in health-food stores," Spira said.

"We're now in the midst of a large study to look at whether or not activity of this pathway can be used to pick those who could benefit from this as a treatment as opposed to just prevention," said Spira, who is a co-founder of Allegro Diagnostics Inc., a company that plans to market this biomarker.

The researchers also need to explore whether or not the PI3K pathway is active in non-smokers, as well as what other pathways might also trigger lung cancer.

The study findings were published in the April 7 issue of the journal Science Translational Medicine.

More information

The U.S. National Cancer Institute has more on lung cancer.



SOURCES: Patrick Nana-Sinkam, M.D., lung cancer expert, the Ohio State University Comprehensive Cancer Center, and co-director of research programs, division of pulmonary, allergy, critical care and sleep medicine, Ohio State University Medical Center, Columbus; Avrum Spira, M.D., pulmonary and critical care physician, Boston Medical Center, and associate professor of medicine, pathology and bioinformatics, Boston University School of Medicine, Boston; Andrea H. Bild, Ph.D., assistant professor of pharmacology and toxicology, University of Utah, Salt Lake City; April 7, 2010, Science Translational Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. The Simple and Revolutionary Power to OUTSMART YOUR GENES Out April 6th -- Predictive Medicine Pioneer Dr. Brandon Colby Releases Book
2. Simple Forms Help Docs Do Better Breast Exams
3. Many With Arthritis Find Simple Solutions for Relief
4. NationalCreditReport.com Offers Simple Tax Saving Tips That Can Improve Credit Scores
5. UAB-led study shows simple steps could reduce stillbirths by up to 1 million
6. Simple Concussion Test Measures Reaction Time
7. Father Channels His Grief into Advocacy, Promotes Simple Actions to Make Hospitals Safer for Children
8. SimpleWebBox Offers Free Websites for Non-Profit Organizations
9. Monkey Brain Hardwired for Simple Math
10. Shamy & Shamy Launches New Web Site Providing Simple Access to Free Online Resources for New Jersey Court System
11. Childhood Cancer Survivors At Higher Odds of Early Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... 22, 2017 , ... Drs. Jennifer Houck, Lauren Smith, Heather Johnson and the ... in need of skilled pediatric dentistry in Rock Hill, SC, without a ... routine treatments, including cavities, sealants and fluoride applications, in a comfortable and fun environment. ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Carballo Agency, a comprehensive ... New York metropolitan region, is embarking on a cooperative charity drive with Family ... present, more than two and a half million children in the United States ...
(Date:3/22/2017)... ... 2017 , ... Schneider Insurance and Financial, a southern Montana firm providing asset ... region, is launching a charity event aimed at raising local support for Zoo Montana. ... State, and is home to a broad variety of animals from all over the ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Senior Citizens ... and prevent a default on the federal debt — including the debt held by ... growing concern, ” said TSCL in a letter to House and Senate budget leaders. ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... Sharon Kleyne ... created more than two decades ago to research evaporation of earth’s and the body’s ... promotes better health. Also the host of the nationally syndicated radio program, The Sharon ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... MAPLE GROVE, Minn. , March 22, 2017   ... of Clomipramine Hydrochloride Capsules* USP, 25 mg, 50 mg and ... (clomipramine hydrochloride) Capsules USP. The clomipramine ... for the 12 months ending December 2016, according to IMS ... ...
(Date:3/22/2017)... 2017  Levine Cancer Institute today launched the ... to address lung cancer diagnosis, treatment and survival ... mobile lung unit is the first-of-its-kind to link ... interventions through integrated mobile technology, traditional treatment facilities ... and a lack of public transportation are barriers ...
(Date:3/22/2017)... 22, 2017  Varex Imaging Corporation (Nasdaq: ... renewed three-year pricing agreement with Toshiba Medical Systems under ... tomography (CT) tubes for integration into Toshiba Medical,s CT ... will be effective April 1, 2017. Potential ... are estimated to be in the range of $345 ...
Breaking Medicine Technology: